Skip to main content
Clinical Trials/CTRI/2024/05/066858
CTRI/2024/05/066858
Not yet recruiting
Phase 2

Single arm clinical study to evaluate the efficacy of Phalapriyangvadi Churna in purishaja krimi. - NI

Dr Tejas Manik Bodke0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: B839- Helminthiasis, unspecified
Sponsor
Dr Tejas Manik Bodke
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Tejas Manik Bodke

Eligibility Criteria

Inclusion Criteria

  • 1\.Children age between 2 to 12 years of both male and female gender.
  • 2\.The patients presenting the signs and symptoms of krimi such as Vivarnata (Skin Pigmentation),Udarshul (Abd pain),Gudkandu (itching near anal region),MalaVishtambhata (constipation),Aganimandya(Anorexia),Vivarnata (Pityriasis alba)
  • 3\.The patients whose parents are ready to participate in the clinical trial by giving informed written consent

Exclusion Criteria

  • 1\.Patients having life threatening illness and who is bed ridden.
  • 2\.Patients who are known case of chronic systemic illness.
  • 3\.Patients having severe abdominal pain \& fever.

Outcomes

Primary Outcomes

Not specified

Similar Trials